Presence of anti-nuclear antibodies is a risk factor for the appearance of anti-drug antibodies during infliximab or adalimumab therapy in patients with rheumatoid arthritis

• Ayano Mori,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft

  Affiliation The Shinko Institute for Medical Research, Shinko Hospital, Kobe, Japan

  ⨯
• Toshiharu Saito,

  Roles Conceptualization, Data curation, Investigation, Methodology, Supervision, Visualization

  Affiliation The Shinko Institute for Medical Research, Shinko Hospital, Kobe, Japan

  ⨯
• Miho Takahashi,

  Roles Data curation, Formal analysis, Investigation, Methodology

  Affiliation The Shinko Institute for Medical Research, Shinko Hospital, Kobe, Japan

  ⨯
• Miho Shibata,

  Roles Data curation, Formal analysis, Investigation, Methodology

  Affiliation The Shinko Institute for Medical Research, Shinko Hospital, Kobe, Japan

  ⨯
• Goh Tsuji,

  Roles Conceptualization, Data curation, Project administration, Supervision

  Affiliation The Center for Rheumatic Disease, Shinko Hospital, Kobe, Japan

  ⨯
• Saori Hatachi,

  Roles Data curation, Project administration, Supervision, Visualization

  Affiliation The Center for Rheumatic Disease, Shinko Hospital, Kobe, Japan

  ⨯
• Soshi Takahashi,

  Roles Formal analysis, Funding acquisition, Investigation, Writing – review & editing

  Affiliations The Shinko Institute for Medical Research, Shinko Hospital, Kobe, Japan, The Center for Rheumatic Disease, Shinko Hospital, Kobe, Japan

  ⨯
• Shunichi Kumagai

  Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Supervision, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: kumagais@kobe-u.ac.jp

  Affiliations The Shinko Institute for Medical Research, Shinko Hospital, Kobe, Japan, The Center for Rheumatic Disease, Shinko Hospital, Kobe, Japan

  https://orcid.org/0000-0002-0352-7903

  ⨯